Showing results (561-570 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|June 23, 2024
The Glass Wall: Gendered Authorship Disparities in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and MyelomaAroog Khaliq, William Wesson, Emerson Logan, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 20, 2024
The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the ConnectⓇ MM RegistryRafat Abonour, Hans C Lee, Robert Rifkin, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2024
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With TalquetamabAjai Chari, Amrita Krishnan, Leo Rasche, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2024
Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating AgentsGuillermo Garcia-Manero, Rayna K Matsuno, Ali McBride, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2024
SOHO State of the Art Updates and Next Questions | Current Evidence and Future Directions for Bispecific Antibodies in Large B-Cell LymphomaRory Bennett, Michael Dickinson
Clinical Lymphoma, Myeloma & Leukemia|June 9, 2024
Unmet Needs in the First-Line Treatment of Diffuse Large B-cell Lymphoma: Expert Recommendations From the Asia-Pacific Region With a Focus on the Challenging SubtypesDaryl Tan, Jason Yongsheng Chan, Kitsada Wudhikarn, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 2, 2023
Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United StatesStefan K Barta, Nicholas Liu, Maral DerSarkissian, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 22, 2023
Full-Dose Azacitidine in 5 Days Versus 7 Days With a Weekend Break in Myelodysplastic Syndromes: A Retrospective Cohort StudyGuilherme Sapinho, Lídia Alves-Ribeiro, Joana Infante, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 20, 2023
Efficacy and Safety of Immune Checkpoint Inhibitors in Hematologic MalignanciesMuhammed Talha Bilgihan, Ayse Nur Eryigit, Rafiye Ciftciler
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2023
Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic ReviewHamlet Gasoyan, Mark A Fiala, Michelle Doering, et al.
Pageof 251